Matrix metalloproteinases in squamous cell carcinoma

Histology and Histopathology

Volumn 15, Issue 1, 2000, Pages 225-237

  Johansson, N ^a   Kähäri, Veli Matti ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Invasion; Matrix; Metalloproteinase; Squamous cell carcinoma

Indexed keywords

COLLAGENASE; ENZYME PRECURSOR; GELATINASE; MATRIX METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

CANCER INVASION; CARCINOGENESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME SUBSTRATE; HUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION;

CARCINOMA, SQUAMOUS CELL; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 19244376146     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (147)

1. Aho M., Vesterinen E., Meyer B., Purola E. and Paavonen J. (1991). Natural history of vaginal intraepithelial neoplasia. Cancer 68, 195-197.
2. Ahonen M., Baker A.H. and Kähäri V.-M. (1998). Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res. 58, 2310-2315.
3. Aimes R.T. and Quigley J.P. (1995). Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4-and 1/4-length fragments. J. Biol. Chem. 270, 5872-5876.
4. Airola K., Johansson N., Kariniemi A.-L., Kähäri V.-M. and Saarialho-Kere U. (1997). Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J. Invest. Dermatol. 109, 225-231.
5. Airola K., Ahonen M., Johansson N., Heikkilä P., Kere J., Kähäri V.-M. and Saarialho-Kere U. (1998). Human TIMP-3 is expressed during fetal development, hair growth cycle, and cancer progression. J. Histochem. Cytochem. 46, 437-447.
6. Apte S.S., Olsen B.R. and Murphy G. (1995). The gene structure of tissue inhibitor of metalloproteinases (TIMP)-S and its inhibitory activities define the distinct TIMP gene family. J. Biol. Chem. 270, 14313-14318.
7. Balbín M., Fueyo A., Knäuper V., Pendás A.M., López J.M., Jimenez M.G., Murphy G. and López-Otín C. (1998). Collagenase 2 (MMP-8) expression in murine tissue-remodeling processes. Analysis of its potential role in postpartum involution of the uterus. J. Biol. Chem. 273, 23959-23968.
8. Basset P., Bellocq J.P., Wolf C., Stoll I., Hutin P., Limacher J.M. Podhajcer O.L., Chenard M.P., Rio M.C. and Chambon P. (1990). A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348, 699-704.
9. Basset P., Okada A., Chenard M.P., Kannan R., Stoll I., Anglard P., Bellocq J.P. and Rio M.C. (1997). Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutical implications. Matrix Biol. 15, 535-541.
10. Belaaouaj A., Shipley J.M., Kobayashi D.K., Zimonjic D.B., Popescu N., Silverman G.A. and Shapiro S.D. (1995). Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J. Biol. Chem. 270, 14568-14575.
11. Benbow U. and Brinckerhoff C.E. (1997). The AP-1 site and MMP gene regulation: What is all the Fuss about ? Matrix Biol. 15, 519-526.
12. Birkedal-Hansen H., Moore W.G., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A. and Engler J.A. (1993). Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4, 197-250.
13. Bolon I., Gouyer V., Devouassoux M., Vandenbunder B., Wernert N., Moro D., Brambilla C. and Brambilla E. (1995). Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am. J. Pathol. 147, 1298-1310.
14. Borchers A.H., Steinbauer H., Schafer B.S., Kramer M., Bowden G. and Fusenig N.E. (1997). Fibroblast-directed expression and localization of 92-kDa type IV collagenase along the tumor-stroma interface in an in vitro three-dimensional model of human squamous cell carcinoma. Mol. Carcinog. 19, 258-266.
15. Brown P.D. (1998). Synthetic inhibitors of matrix metalloproteinases. In: Matrix metalloproteinases. Mecham R. and Parks W.C. (eds). San Diego. Academic Press. pp 243-262.
16. Burman J.F. and Carter R.L. (1985). Lysis of type-I collagen by squamous carcinomas of head and neck. Int. J. Cancer 36, 109-116.
17. Butler G.S., Butler M.J., Atkinson S.J., Will H., Tamura T., van Westreum S.S., Crabbe T., Clements J., d'Ortho M.-P. and Murpy G. (1998). The TIMP-2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. J. Biol. Chem 273, 871-880.
18. Cao J., Sato H., Takino T. and Seiki M. (1995). The C-terminal region of membrane type matrix metalloproteinase is a functional trans-membrane domain required for pro-gelatinase A activation. J. Biol. Chem. 270, 801-805.
19. Cazorla M., Hernandez L., Nadal A., Balbín M., Lopez J.M., Vizoso F., Fernandez P.L., Iwata K., Cardesa A., López-Otín C. and Campo E. (1998). Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J. Pathol. 186, 144-150.
20. Chandler S., Cossin J., Lury J. and Wells G. (1996). Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumor necrosis factor-a fusion protein. Biochem. Biophys. Res. Commun. 228, 421-429.
21. Chandler S., Miller K.M., Clements J.M., Lury J., Corkill D., Anthony D.C., Adams S.E. and Gearing A.J. (1997). Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J. Neuroimmunol. 72, 155-161.
22. Cole A.A., Chubinskaya S., Schumacher B., Huch K., Szabo G., Yao J., Mikecz K., Hasty K.A. and Kuettner K.E. (1996). Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. J. Biol. Chem. 271, 11023-11026.
23. Cossins J., Dudgeon T.J., Catlin G., Gearing A.J. and Clements J.M. (1996). Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem. Biophys. Res. Commun. 228, 494-498.
24. Dong Z., Kumar R., Yang X. and Fidler I.J. (1997). Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88, 801-810.
25. Douglas D.A., Shi Y.E. and Sang Q.A. (1997). Computational sequence analysis of tissue inhibitor of metalloproteinase family. J. Prot. Chem. 16, 237-255.
26. Dunsmore S.E., Saarialho-Kere U.K., Roby J.D., Wilson C.L., Matrisian L.M., Welgus H.G. and Parks W.C. (1998). Matrilysin expression and function in airway epithelium. J. Clin. Invest. 102, 1321-1331.
27. d'Ortho M.P., Will H., Atkinson S., Butler G., Messent A., Gavrilovic J., Smith B., Timpl R., Zardi L. and Murphy G. (1997). Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur. J. Biochem. 250, 751-757.
28. Franks L.M. and Teich N.M. (1997). Introduction to the cellular and molecular biology. 3rd ed. Oxford University Press. Oxford.
29. Fosang A.J., Last K., Knäuper V., Murphy G. and Neame P.J. (1996). Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett. 380, 17-20.
30. Freije J.M., Diez-ltza I., Balbín M., Sanchez L.M., Blasco R., Tolivia J. and López-Otín C. (1994). Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem. 269, 16766-16773.
31. Fridman R., Toth M., Pena D. and Mobashery S. (1995). Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res. 55, 2548-2555.
32. Giambernardi T.A., Grant G.M., Taylor G.P., Hay R.J., Maher V.M., McCormick J.J. and Klebe R.J. (1998). Overview of matrix metalloproteinase expression in cultured human cells. Matrix Biol. 16, 483-496.
33. Gilles C., Polette M., Piette J., Munaut C., Thompson E.W., Birembaut P. and Foidart J.M. (1996). High level of MT-MMP expresssion is associated with invasiveness of cervical cancer cells. Int. J. Cancer 65, 209-213.
34. Goldberg G.I., Wilhelm S.M., Kronberger A., Bauer E.A., Grant G.A. and Eisen A.Z. (1986). Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J. Biol. Chem. 261, 6600-6605.
35. Gomez D.E., Alonso D.F., Yoshiji H. and Thorgeirsson U.P. (1997). Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74, 111-122.
36. Gray S.T., Wilkins R.J. and Yun K. (1992). Interstitial collagenase gene expression in oral squamous cell carcinoma. Am. J. Pathol. 141, 301-306.
37. Greene J., Wang M., Liu Y.E., Raymond L.A., Rosen C. and Shi Y.E. (1996). Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem. 271, 30375-30380.
38. Gum R., Wang H., Lengyel E., Juarez J. and Boyd D. (1997). Regulation of 92 kDa type IV collagenase expression of the jun aminoterminal kinase-and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14, 1481-1493.
39. Guo H., Zucker S., Gordon M.K., Toole B.P. and Biswas C. (1997). Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J. Biol. Chem. 272, 24-27.
40. Hanemaaijer R., Sorsa T., Konttinen Y.T., Ding Y., Sutinen M., Visser H., van Hinsbergh V.W.M., Helaakoski T., Kainulainen T., Rönkä H., Tschesche H. and Salo T. (1997). Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. J. Biol. Chem. 272, 31504-31509.
41. Hasty K.A., Hibbs M.S., Kang A.H. and Mainardi C.L. (1986). Secreted forms of human neutrophil collagenase. J. Biol. Chem. 261, 5645-5650.
42. Hasty K.A., Jeffrey J.J., Hibbs M.S. and Welgus H.G. (1987). The collagen substrate specificity of human neutrophil collagenase. J. Biol. Chem. 262, 10048-10052.
43. Hasty K.A., Pourmotabbed T.F., Goldberg G.I., Thompson J.P., Spinella D.G., Stevens R.M. and Mainardi C.L. (1990). Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J. Biol. Chem. 265, 11421-11424.
44. He C., Wilhelm S.M., Pentland A.P., Marmer B.L., Grant G.A., Eisen A.Z. and Goldberg G.I. (1989). Tissues cooperation in a proteolytic cascade activating human interstitial collagenase. Proc. Natl. Acad. Sci. USA 86, 2632-2636.
45. Heino J. (1996). Biology of tumor cell invasion: interplay of cell adhesion and matrix degradation. Int. J. Cancer 65, 717-722.
46. Heppner K.J., Matrisian L.M., Jensen R.A. and Rodgers W.H. (1996). Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am. J. Pathol. 149, 273-282.
47. Hording U., Junge J., Daugaard S., Lundvall F., Poulsen H. and Bock J.E. (1994). Vulvar squamous cell carcinoma and papillomaviruses: indications for two different etiologies. Gynecol. Oncol. 52, 241-246.
48. Iozzo R.V. (1995). Tumor stroma as a regulator of neoplastic behavior. Agonistic and antagonistic elements embedded in the same connective tissue. Lab. Invest. 73, 157-160.
49. Ito A., Mukaiyama A., Itoh Y., Nagase H., Thogersen I.B., Enghild J.J., Sasaguri Y. and Mori Y. (1996). Degradation of interleukin-1ß by matrix metalloproteinases. J. Biol. Chem. 271, 14657-14660.
50. Itoh T., Tanioka M., Yoshida H., Yoshioka T., Nishimoto H. and Itohara S. (1998). Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58, 1048-1051.
51. Johansson N., Saarialho-Kere U., Airola K., Herva R., Nissinen L., Westermarck J., Vuorio E., Heino J. and Kähäri V-M. (1997a). Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev. Dyn. 208, 387-397
52. Johansson N., Westermarck J., Leppä S., Häkkinen L., Koivisto L., López-Otín C., Peltonen J., Heino J. and Kähäri V.-M. (1997b). Collagenase-3 (Matrix metalloproteinase-13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor-a and transforming growth factor-ß. Cell Growth Differ. 8, 243-250.
53. Johansson N., Airola K., Grénman R., Kariniemi A.-L., Saarialho-Kere U. and Kähäri V.-M. (1997c). Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am. J. Pathol. 151, 499-508.
54. Johansson N., Vaalamo M., Grénman S., Hietanen S., Klemi P., Saarialho-Kere U. and Kähäri V-M. (1999). Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am. J. Pathol. 154, 469-480
55. Johnsen M., Lund L.R., Romer J., Almholt K. and Kanoø K. (1998). Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr. Opin. Cell Biol. 10, 667-671.
56. Kagie M.J., Kenter G.G., Zomerdijk-Nooijen Y., Hermans J., Schuuring E., Timmers P.J., Trimbos J.B. and Fleuren G.J. (1997). Human papillomavirus infection in squamous cell carcinoma of the vulva, in various synchronous epithelial changes and in normal vulvar skin. Gynecol. Oncol. 67, 178-183.
57. Kähäri V.-M. and Saarialho-Kere U. (1997). Matrix metalloproteinases in skin. Exp. Dermatol. 6, 199-213.
58. Kähäri V.-M. and Saarialho-Kere U. (1999). Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann. Med. 31, 34-45.
59. Karelina T.V., Goldberg G.I. and Eisen A.Z. (1994). Matrilysin (PUMP) correlates with dermal invasion during appendageal development and cutaneous neoplasia. J. Invest. Dermatol. 103, 482-487.
60. Karin M., Liu Z.G. and Zandi E. (1997). AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240-246.
61. Kauppila S., Saarela J., Stenbäck F., Risteli J., Kauppila A. and Risteli L. (1996). Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomas. Am. J. Pathol. 148, 539-548.
62. Kawamata H., Uchida D., Hamano H., Kimura-Yanagawa T., Nakashiro K., Hino S., Omotehara F., Yoshida H. and Sato M. (1998). Active MMP-2 in cancer cell nests of oral cancer patiens: correlation with lymph node metastasis. Int. J. Oncol. 13, 699-704.
63. Kishnani N.S., Staskus P.W., Yang T.T., Masiarz F.R. and Hawkes S.P. (1995). Identification and characterization of human tissue inhibitor of metalloproteinase-3 and detection of three additional metalloproteinase inhibitor activities in extracellular matrix. Matrix Biol. 14, 479-488.
64. Knäuper V., López-Otín C., Smith B., Knight G. and Murphy G. (1996a). Biochemical characterization of human collagenase-3. J. Biol. Chem. 271, 1544-1550.
65. Knäuper V., Will H., López-Otín C., Smith B., Atkinson S.J., Stanton H., Hembry R.M. and Murphy G. (1996b). Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J. Biol. Chem. 271, 17124-17131.
66. Knäuper V., Cowell S., Smith B., López-Otín C., O'Shea M., Morris H., Zardi L. and Murphy G. (1997a). The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J. Biol. Chem 272, 7608-7016.
67. Knäuper V., Smith B., López-Otín C. and Murphy G. (1997b). Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur. J. Biochem. 248, 369-373.
68. Krag K.J. (1991). Gynecologic tumors and malignancies. In: Atlas of diagnostic oncology. Skarin A.T. (ed.) J.B. Lippincott Co. Philadelphia. pp 5.2-5.38.
69. Krane S.M., Byrne M.H., Lemaitre V., Henriet P., Jeffrey J.J., Witter J.P., Liu X., Wu H., Jaenisch R. and Eeckhout Y. (1996). Different collagenase gene products have different roles in degradation of type I collagen. J. Biol. Chem. 271, 28509-28515.
70. Kusukawa J., Sasaguri Y., Morimatsu M. and Kameyama T. (1995). Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity. J. Oral. Maxillofac. Surg. 53, 530-534.
71. Leco K.J., Khokha R., Pavloff N., Hawkes S.P. and Edwards D.R. (1994). Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J. Biol. Chem. 269, 9352-9360.
72. Lengyel E., Gum R., Juarez J., Clayman G., Seiki M., Sato H. and Boyd D. (1995). Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. Cancer Res. 55, 963-967.
73. Lever W.F. and Schaumburg-Lever G. (1990). Histopathology of the skin. JB Lippincott. Philadelphia.
74. Lijnen H.R, Ugwu F., Bini A. and Collen D. (1998). Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3). Biochemistry 37, 4699-4702.
75. Lindy O., Konttinen Y.T., Sorsa T., Ding Y., Santavirta S., Ceponis A. and López-Otín C. (1997). Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum. 40, 1391-1399.
76. Liotta L.A., Steeg P.S. and Stetler-Stevenson W.G. (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64, 327-336.
77. Liu X,. Wu H., Byrne M., Jeffrey J., Krane S. and Jaenisch R. (1995). A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J. Cell Biol. 130, 227-237.
78. Llano E., Pendás A.M., Käuper V., Sorsa T., Salo T., Salido E., Murphy G., Simmer J.P., Bartlett J.D. and López-Otín C. (1997). Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry 36, 15101-15108.
79. Lohi J., Lehti K., Westermarck J., Kähäri V.-M. and Keski-Oja J. (1996). Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur. J. Biochem. 239, 239-247.
80. Masson R., Lefebreve O., Noel A., El Fahime M., Chenared M.-P., Wendling C., Kebers F., LeMeur M., Dierich A., Foidart J.-M., Basset P. and Rio M.C. (1998). In vivo evidence that stromelysin-3 metalloproteinase contributes in a paracrine manner in epithelial cell malignancies. J. Cell Biol. 140, 1535-1541.
81. Matsumoto S., Katoh M., Saito S., Watanabe T. and Masuho Y. (1997). Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA. Biochim. Biophys. Acta 1354, 159-170.
82. Mattila L., Airola K., Ahonen M., Hietarinta M., Black C., Saarialho-Kere U. and Kähäri V-M. (1998). Activation of tissue inhibitor of metalloproteinases-3 (TIMP-3) mRNA expression in scleroderma skin fibroblasts. J. Invest. Dermatol. 110, 416-421.
83. Mitchell P.G., Magna H.A., Reeves L.M., Lopresti Morrow L.L., Yocum S.A., Rosner P.J., Geoghegan K.F. and Hambor J.E. (1996). Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97, 761-768.
84. Moldovan F., Pelletier J.P., Hambor J., Cloutier J.M. and Martel-Pelletier J. (1997). Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor-ß. Arthritis. Rheum. 40, 1653-1661.
85. Muller D., Breathnach R., Engelmann A., Millon R., Bronner G., Flesch H., Dumont P., Eber M. and Abecassis J. (1991). Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int. J. Cancer 48, 550-556.
86. Muller D., Wolf C., Abecassis J., Millon R., Engelmann A., Bronner G., Rouyer N., Rio M.C., Eber M., Methlin G., Chambon P. and Basset P. (1993). Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res. 53, 165-169.
87. Murphy G. and Knäuper V. (1997). Relating matrix metalloproteinase structure to function: why the "hemopexin" domain? Matrix Biol. 15, 511-518.
88. Murray G.I., Duncan M.E., O'Neil P., McKay J.A., Melvin W.T. and Fothergill J.E. (1998). Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J. Pathol. 185, 256-261.
89. Nagase H. (1997). Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378, 151-160.
90. Nuovo G.J. (1997). In situ detection of PCR-amplified metalloproteinase cDNAs, their inhibitors and human papillomavirus transcripts in cervical cell lines. Int. J. Cancer 71, 1056-1060.
91. Ohuchi E., Imai K., Fujii Y., Sato H., Seiki M. and Okada Y. (1997). Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272, 2446-2451.
92. Okada A., Bellocq J.P., Rouyer N., Chenard M.P., Rio M.C., Chambon P. and Basset P. (1995a). Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl. Acad. Sci. USA 92, 2730-2734.
93. Okada Y., Nara K., Kawamura K., Matsumoto T., Nakanishi I., Fujimoto N., Sato H. and Seiki M. (1995b). Localization of matrix metalloproteinase-9 (92 KDa gelatinase/type IV collagenase=gelatinase B) in osteoclasts; implications for bone resorption. Lab. Invest. 72, 311-322.
94. Patterson B.C. and Sang Q.A. (1997). Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 272, 28823-28825.
95. Pei D. and Weiss S.J. (1995). Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375, 244-247.
96. Pei D., Majmudar G. and Weiss S.J. (1994). Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J. Biol. Chem. 269, 25849-25855.
97. Pendás A.M., Balbín M., Llano E., Jiménez M.G. and López-Otín C. (1997a). Structural analysis and promoter characterization of the human collagenase-3 gene (MMP-13). Genomics 40, 222-233.
98. Pendás A.M., Knäuper V., Puente X.S., Llano E., Mattei M.G., Apte S., Murphy G. and López-Otín C. (1997b). Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J. Biol. Chem. 272, 4281-4286.
99. Polette M., Clavel C., Muller D,. Abecassis J., Binninger I. and Birembaut P. (1991). Detection of mRNAs encoding collagenase I and stromelysin 2 in carcinomas of the head and neck by in situ hybridization. Invasion Metastasis 11, 76-83.
100. Puente X.S., Pendás A.M., Llano E., Velasco G. and López-Otín C. (1996). Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res. 56, 944-949.
101. Pyke C., Ralfkiaer E., Huhtala P., Hurskainen T., Danoø K. and Tryggvason K. (1992). Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancer by in situ hybridization. Cancer Res. 52, 1336-1341.
102. Ravanti L., Heino J., López-Otín C. and Kähäri V-M. (1999). Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 274, 2446-2455.
103. Reboul P., Pelletier J.P., Tardif G., Cloutier J.M. and Martel-Pelletier J. (1996). The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J. Clin. Invest. 97, 2011-2019.
104. Reunanen N., Westermarck J., Häkkinen L., Holmström T.H., Elo I., Eriksson J.E. and Kähäri V.-M. (1998). Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J. Biol. Chem. 273, 5137-5145.
105. Saarialho-Kere U.K. (1998). Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch. Dermatol. Res. 290 Suppl, S47-54.
106. Saarialho-Kere U.K., Crouch E.G. and Parks W.C. (1995). Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J. Invest. Dermatol. 105, 190-196.
107. Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto E. and Seiki M. (1994). A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 616-615.
108. Sato H., Kinoshita T., Takino T., Nakayama K. and Seiki M. (1996a). Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett. 393, 101-104.
109. Sato H., Takino T., Kinoshita T., Imai K., Okada Y., Stetler-Stevenson W.G. and Seiki M. (1996b). Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett. 385, 238-240.
110. Sato T., del Carmen Ovejero M., Hou P., Heegaard A.M., Kumegawa M., Foged N.T. and Delaisse J.M. (1997). Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. J. Cell. Sci. 110, 589-596.
111. Sawatsubashi M., Mizokami H., Tokunaga O. and Shin T. (1998). Expression of MMP-1, TIMP-1 and type I collagen in laryngeal carcinoma. Mod. Pathol. 11, 878-885.
112. Shapiro S.D. (1998). Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr. Opin. Cell Biol. 10, 602-608.
113. Shapiro S.D., Kobayashi D.K. and Ley T.J. (1993). Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 268, 23824-23829.
114. Shlopov B.V., Lie W.R., Mainardi C.L., Cole A.A. Chubinskaya S. and Hasty K.A. (1997). Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum. 40, 2065-2074.
115. Shofuda K.I., Yasumitsu H., Nishihashi A., Miki K., and Miyazaki K. (1997). Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without transmembrane domain. J. Biol. Chem. 272, 9749-9754.
116. Simon C., Goepfert H. and Boyd D. (1998). Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res. 58, 1135-1139.
117. Ståhle-Bäckdahl M. and Parks W.C. (1993). 92-kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. Am. J. Pathol. 142, 995-1000.
118. Ståhle-Bäckdahl M., Sandstedt B., Bruce K., Lindahl A., Jimenez M., Vega J. and López-Otín C. (1997). Collagenase-3 (MMP-13) is expressed during human fetal ossif cation and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab. Invest. 76, 717-728.
119. Stetler-Stevenson W.G., Aznavoorian S. and Liotta L.A. (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9, 541-573.
120. Storey A., Thomas M., Kalita A., Harwood C., Gardiol D., Mantovani F., Breuer J., Leigh I.M., Matlashewski G. and Banks L. (1998). Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393, 229-234.
121. Sutinen M. Kainulainen T., Hurskainen T., Vesterlund E., Alexander J.P., Overall C.M., Sorsa T. and Salo T. (1998). Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br. J. Cancer 77, 2239-2245.
122. Takino T., Sato H., Shinagawa A. and Seiki M. (1995). Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J. Biol. Chem. 270, 23013-23020.
123. Tamakoshi K., Kikkawa F., Nawa A., Ishikawa H., Mizuno K., Tamakoshi A., Yamagata S., Suganuma N. and Tomodo Y. (1995). Characterization of extracellular matrix degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form. Cancer 76, 2565-2571.
124. Tardif G., Pelletier J.P., Dupuis M., Hambor J.E. and Martel-Pelletier J. (1997). Cloning, sequencing and characterization of the 5'-flanking region of the human collagenase-3 gene. Biochem. J. 323, 13-16.
125. Templeton N.S. and Stetler-Stevenson W.G. (1991). Identification of a basal promoter for the human Mr 72,000 type IV collagenase gene and enhanced expression in a highly metastatic cell line. Cancer Res. 51, 6190-6193.
126. Tetlow L.C. and Woolley D.E. (1998). Comparative immunolocalization studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro. Br. J. Rheumatol. 37, 64-70.
127. Uitto V.-J., Airola K., Vaalamo M., Johansson N., Putnins E.E., Firth J.D., Salonen J., López-Otín C., Saarialho-Kere U. and Kähäri V-M. (1998). Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am. J. Pathol. 152, 1489-1499.
128. Uría J.A., Ståhle-Bäckdahl M., Seiki M., Fueyo A. and López-Otín C. (1997). Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res. 57, 4882-4888.
129. Uría J.A., Balbín M., López J.M., Alvarez J., Vizoso F., Takigawa M. and López-Otín C. (1998). Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am. J. Pathol. 153, 91-101.
130. Vaalamo M., Mattila L., Johansson N., Kariniemi A.-L., Karjalainen-Lindsberg M.-L., Kähäri V.-M. and Saarialho-Kere U.K. (1997). Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J. Invest. Dermatol. 109, 96-101.
131. Vaalamo M., Karjalainen-Lindsberg M.-L., Puolakkainen P., Kere J. and Saarialho-Kere U.K. (1998). Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am. J. Pathol. 152, 1005-1014.
132. Vaalamo M., Kariniemi A.-L., Shapiro S.D. and Saarialho-Kere U. (1999). Enhanced expression of human metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration. J. Invest. Dermatol. 112, 499-505.
133. van Wart H.E. and Birkedal-Hansen H. (1990). The cystein switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. USA 87, 5578-5582.
134. von Bredow D.C., Nagel R.B., Bowden G.T. and Cress A.E. (1997). Cleavage of ß4 integrin by matrilysin. Exp. Cell Res. 236, 341-345.
135. Wagner S.N, Ockenfels H.M., Wagner C., Soyer H.P. and Goos M. (1996). Differential expression of tissue inhibitor of metalloproteinases-2 by cutaneous squamous and basal cell carcinomas. J. Invest. Dermatol. 106, 321-326.
136. Wasylyk C., Gutman A., Nicholson R. and Wasylyk B. (1991). The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J. 10, 1127-1134.
137. Wernert N., Raes M.B., Lassalle P., Dehouck M.P., Gosselin B., Vandenbunder B. and Stehelin D. (1992). c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am. J. Pathol. 140, 119-127.
138. Wernert N., Gilles F., Fafeur V., Bouali F., Raes M.B., Pyke C., Dupressoir T., Seitz G., Vandenbunder B. and Stehelin D. (1994). Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res. 54, 5683-5688.
139. Westermarck J. and Kähäri V.-M. (1999). Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13, 781-792.
140. Westermarck J., Seth A. and Kähäri V-M. (1997). Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene 14, 2651-2660.
141. Westermarck J., Holmström T.H., Ahonen M., Eriksson J.E. and Kähäri V.-M. (1998). Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by Jun N-terminal kinase and p38 stress-activated protein kinase. Matrix Biol. 17, 547-557.
142. Will H. and Hinzmann B. (1995). cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem. 231, 602-608.
143. Wilson C.L. and Matrisian L.M. (1996). Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int. J. Biochem. Cell Biol. 28, 123-136.
144. Wilson C.L., Heppner K.J., Labosky P.A., Hogan B.L. and Matrisian L.M. (1997). Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. USA 94, 1402-1407.
145. Windsor L.J., Grenett H., Birkedal-Hansen B., Bodden M.K., Engler J.A. and Birkedal-Hansen H. (1993). Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbol esters. J. Biol. Chem. 268, 17341-17347.
146. Yoshizaki T., Sato T., Maruyama Y., Murono S., Furukawa M., Park C.S. and Seiki M. (1997). Increased expression of membrane type-1 metalloproteinase in head and neck carcinoma. Cancer 79, 139-144.
147. Zucker S., Drews M., Conner C., Foda H.D., DeClerck Y.A., Langley K.E., Bahou W.F., Docherty A.J.P. and Cao J. (1998). Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J. Biol. Chem. 273, 1216-1222.